CIK: 0001839948 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $959,502 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY, INC. | 3,670,206 | $115,868 | 12.1% | $40.67 | -14.8% | COMM | 156944100 |
| DYN | DYNE THERAPEUTICS, INC | 2,650,150 | $93,524 | 9.7% | $16.62 | +74.8% | COMM | 26818M108 |
| ABVX | Abivax SA | 6,056,596 | $80,068 | 8.3% | $12.76 | — | ADRS | 00370M103 |
| SLN | SILENCE THERAPEUTICS PLC | 3,295,350 | $62,612 | 6.5% | $14.21 | — | ADRS | 82686Q101 |
| COGT | COGENT BIOSCIENCES INC | 6,964,375 | $58,710 | 6.1% | $9.05 | -16.2% | COMM | 19240Q201 |
| SVRA | SAVARA INC. | 12,362,205 | $49,820 | 5.2% | $3.73 | +19.2% | COMM | 805111101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 149,283 | $41,823 | 4.4% | $110.42 | +115.6% | COMM | 558868105 |
| EWTX | EDGEWISE THERAPEUTICS, INC. | 2,272,728 | $40,932 | 4.3% | $15.89 | +9.7% | COMM | 28036F105 |
| KROS | KEROS THERAPEUTICS, INC. | 879,344 | $40,186 | 4.2% | $59.30 | -9.4% | COMM | 492327101 |
| MLYS | MINERALYS THERAPEUTICS, INC. | 3,185,185 | $37,267 | 3.9% | $12.35 | +2.0% | COMM | 603170101 |
| OCUL | OCULAR THERAPEUTIX, INC. | 5,319,148 | $36,383 | 3.8% | $7.10 | -13.0% | COMM | 67576A100 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $31,806 | 3.3% | $12.71 | +35.5% | COMM | 90240B106 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $29,313 | 3.1% | $14.54 | +41.3% | COMM | 50127T109 |
| GPCR | STRUCTURE THERAPEUTICS INC | 694,547 | $27,275 | 2.8% | $43.22 | — | ADRS | 86366E106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,890,816 | $26,104 | 2.7% | $7.22 | — | COMM | 152309100 |
| — | ASTRIA THERAPEUTICS, INC. | 2,761,861 | $25,133 | 2.6% | $14.07 | — | COMM | 04635X102 |
| CMPS | COMPASS PATHWAYS PLC | 3,858,000 | $23,302 | 2.4% | $7.40 | — | ADRS | 20451W101 |
| — | SOLENO THERAPEUTIVS, INC. | 550,000 | $22,440 | 2.3% | $42.80 | — | COMM | 834203200 |
| IRON | Disc Medicine, Inc. | 486,957 | $21,947 | 2.3% | $33.98 | 0.0% | COMM | 254604101 |
| — | TOURMALINE BIO INC | 1,477,593 | $19,002 | 2.0% | $25.14 | — | COMM | 89157D105 |
| TARS | TARSUS PHARMACEUTICALS, INC. | 556,317 | $15,121 | 1.6% | $17.70 | +90.0% | COMM | 87650L103 |
| — | ADVERUM BIOTECHNOLOGIES, INC. | 2,008,340 | $13,777 | 1.4% | $14.14 | — | COMM | 00773U108 |
| — | VISTAGEN THERAPEUTICS INC | 2,676,580 | $9,314 | 1.0% | $5.14 | — | COMM | 92840H202 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $8,336 | 0.9% | $17.12 | — | COMM | 29384C108 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 922,335 | $8,024 | 0.8% | $13.97 | 0.0% | COMM | 30233G209 |
| CCCC | C4 THERAPEUTICS, INC. | 1,276,574 | $5,898 | 0.6% | $5.83 | +2.3% | COMM | 12529R107 |
| — | NEKTAR THERAPEUTICS | 4,000,000 | $4,960 | 0.5% | $0.93 | — | COMM | 640268108 |
| — | AEROVATE THERAPEUTICS INC | 2,240,809 | $3,720 | 0.4% | $15.50 | — | COMM | 008064107 |
| ANTX | AN2 Therapeutics, Inc. | 1,555,118 | $3,344 | 0.3% | $9.33 | -74.5% | COMM | 037326105 |
| KOD | KODIAK SCIENCES INC | 899,999 | $2,115 | 0.2% | $4.10 | -17.4% | COMM | 50015M109 |
| VTYX | VENTYX BIOSCIENCES, INC | 316,195 | $730 | 0.1% | $29.94 | -86.1% | COMM | 92332V107 |
| CABA | CABALETTA BIO, INC | 86,795 | $649 | 0.1% | $3.64 | +236.6% | COMM | 12674W109 |